Bako Diagnostics News
Bako Diagnostics is committed to providing updates regarding ongoing litigation, as necessary, to ensure that complete and accurate information is available to the podiatric medical community. We do not use email newsletters to communicate this information. To view Bakotic / BakoDx Litigation, click here.
APMAPAC honors Bako Diagnostics with Champion of 2019 Award
BakoDx has served the podiatric medical community for the past 10 years and has shown a deep dedication and passion for the profession. [...]
Bako Diagnostics Mourns the Loss of Diana Brandon
Diana C. Brandon, Vice President of Payors Relations for Bako Diagnostics, passed away peacefully on July 14 at her home in Murrieta, California. Brandon [...]
Bako Diagnostics Announces Tracey C. Vlahovic, DPM, Joins Podiatric Medical Advisory Board
ATLANTA — Bako Diagnostics is pleased to announce that Tracey C. Vlahovic, DPM, has joined its Podiatric Medical Advisory Board. Dr. Vlahovic is a [...]
BakoDx Announces Naghmeh Lilly Khavari, DPM, as Clinical Consultant
Dr. Naghmeh Lilly Khavari ATLANTA — Feb. 7, 2019 — BakoDx is pleased to welcome Dr. Naghmeh Lilly Khavari to its Clinical [...]
BakoDx continues all five national health plan provider relationship in 2019
ATLANTA — Jan. 24, 2019 — Bako Diagnostics continues its strong in-network laboratory status with all five national health plans into 2019. Members covered [...]
Bako Diagnostics is Honored to Support the Podiatric Medical Community
ATLANTA — Jan. 4, 2019 — In 2018, Bako Diagnostics (BakoDx) continued a long tradition of supporting the podiatric medical community. These efforts and [...]
Bako Diagnostics and StrataDx Announce a Strategic Relationship. The Parent Company of Bako Diagnostics, the Leading U.S. Podiatry-focused Pathology Laboratory, has Acquired StrataDx, a Leading Laboratory Focused on Dermatopathology and Oral Pathology
ATLANTA/BOSTON—October 10, 2018— Bako Diagnostics and StrataDx announce a strategic relationship. The parent company of Bako Diagnostics has acquired StrataDx, a leading U.S. dermatopathology [...]
Bako Diagnostics Appoints Ted Hull as Chief Executive Officer
ATLANTA — July 24, 2018 — Bako Diagnostics, a podiatry-focused clinical laboratory and products company, announced today the appointment of Ted Hull as Chief [...]
Bako Diagnostics Expands Clinical Utility of Nail Dystrophy Assay
ATLANTA — July 11, 2018 — Bako Diagnostics (BakoDx), the leader in nail dystrophy diagnostic testing, announced the availability of its expanded molecular test [...]
Bako Diagnostics Announces the Formation of Its Podiatric Advisory Board
ATLANTA. Feb. 26, 2018 – Bako Diagnostics, a podiatry-focused clinical laboratory and products company, announced today that they have formed a Podiatric Advisory Board [...]
Bako Diagnostics Announces Appointments to Clinical Consultant Team – Podiatry Faculty
ATLANTA. Feb. 26, 2018 – Bako Diagnostics, a podiatry-focused clinical laboratory and products company, announced appointments to the Bako Clinical Consultant Team. This Team [...]
Bako Launches New Website for the Podiatric Community – bakodx.com
Company changes name to Bako Diagnostics and redesigns logo to reflect increased clinical laboratory services for podiatrists ATLANTA. Dec. 15 /PRNewswire/ - Bako, [...]